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Piscine (anglerfish, catfish, coho salmon) glucagon-like peptides (GLPs), applied at 3.5 nM, stimulate (1.1- 
1.9-fold) flux through gluconeogenesis above control evels in isolated trout and salmon hepatocytes. Hu- 
man GLP-1 and GLP-2 also activate gluconeogenesis, but to a lesser degree than their piscine counterparts. 
Minor increases of substrate oxidation are noticed at times of peak gluconeogenic a tivation through GLPs. 
These hormones, which are derived from the same precursor peptide as glucagon are more potent activators 
of gluconeogenesis than glucagon when applied at equimolar concentrations, and do not appear to employ 
cAMP or cGMP as the intraceilular messenger in hepatic tissue. 
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1. INTRODUCTION 
In addition to glucagon, other functional pep- 
tide units are coencoded in the preproglucagon 
gene of vertebrates. Interest in these glucagon-like 
peptides (GLPs) has recently led to their isolation 
[1-4], determination of their amino acid sequences 
[1-3] and use of recombinant DNA techniques to 
elucidate homologies within the vertebrate line 
[3,4]. Less is known about any actual physiological 
function or the mechanism of action of these novel 
peptides, which are differentially processed by and 
secreted from vertebrate pancreas or gut [5,6]. On 
the one hand, mammalian GLP-1, GLP,2 and cat- 
fish GLP activate rat brain adenylate cyclase, but 
fail to activate the hepatic enzyme [7,8]. High- 
affinity GLP-1 receptors appear to be absent from 
rat liver membranes and GLP- I  does not alter the 
glucagon-dependent production of hepatocyte 
cAMP [9] which was interpreted to indicate that 
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liver was not a target organ for GLPs [9]. The 
short form of GLP-l(7_37) exerts insulinotropic ac- 
tion on rat islets [10] and on perfused rat pancreas 
[11], while no such role could be attributed to 
mammalian GLP-Io_37 ) or GLP-2 [10,11]. 
Since we and others have recently purified and 
characterized a number of vertebrate GLPs [1-4], 
and because isolated teleost hepatocytes are highly 
sensitive and responsive to hormones [13,14], we 
decided to analyze potential metabolic effects of 
GLPs on fish liver metabolism and investigate 
their possible mode of action. 
2. MATERIALS AND METHODS 
Immature rainbow trout (Salmo gairdneri, 
150-250 g) were maintained on a high protein diet 
at 9-13°C. Saltwater-adapted coho salmon (On- 
corhynchus kisutch, 40-120 g) were kindly sup- 
plied (in March only) by Dr E.M. Donaldson, 
Department of Fisheries and Oceans, West Van- 
couver, and kept at 9°C for less than 6 days 
without feeding. Hepatocytes were isolated by in 
situ collagenase perfusion and subsequent dif- 
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ferential centrifugation [12]. 20-45 mg packed cells 
were used per flask, containing 5 mM L-lactate 
and, after a 20 min preincubation, a total of 
1.8-3.7 kBq L-[U-~4C]lactate were added (final 
volume 1.0 ml). Cells were incubated for 2 h at 
15°C. Incorporation of label into glucose and CO2 
was assessed as described [15]. Hormones or vehi- 
cle were added after the preincubation period. 
Cells used for cAMP and cGMP radioimmuno- 
assay (Amersham kits, Canada) were treated as 
above, but without radiolabel. Cells were in- 
cubated with hormones or vehicle for 15 min 
following a 20 rain preincubation with 5 mM L- 
lactate, cAMP and cGMP were measured in neu- 
tralized perchloric acid extracts using internal and 
external standards. All experiments and analyses 
were done in duplicates in a block design and 
paired t-test was used for statistical analyses. 
Coho salmon, catfish (Ictalurus punctatus) and 
anglerfish (Lophius americanus) GLPs were isol- 
ated as described [1-3]. Human GLP-1 (amidated) 
and GLP-2 were purchased from Bachem and 
Peninsula Labs, respectively. Calbiochem supplied 
bovine glucagon. 
3. RESULTS 
Rainbow trout (table 1) and coho salmon (table 
2) hepatocytes respond to the addition of verte- 
brate GLPs with specific increases in the rate of 
flux through the gluconeogenic pathway. Piscine 
GLPs enhance (13-88%) the flux of carbon 
through the gluconeogenic pathway compared 
with untreated control cells and lead to an in- 
creased synthesis of glucose from radiolabelled lac- 
tate (tables 1,2). All piscine GLPs assayed are 
equally effective in their gluconeogenic action. A 
full metabolic response is elicited at the lowest hor- 
mone concentration applied (3.5 nM). Higher 
doses lead to only minor additional increases in 
gluconeogenic flux (statistically not significantly 
different from the 3.5 nM dose). 
Piscine GLPs also tend to increase the amount 
of lactate carbon the cells funnel into oxidative 
pathways as judged by higher rates of CO2 release 
(tables 1,2). This activation may reflect generally 
stepped-up cellular oxygen uptake concomitant 
with a higher rate of substrate consumption. In 
terms of actual carbon flow (cf. legend to table 1), 
the activation of oxidation is well below the in- 
creased flux through gluconeogenesis. We con- 
clude that, at least in vitro, the activation of 
gluconeogenesis designates one important biolo- 
gical effect of GLP action. 
Since all hepatocyte xperiments were perform- 
ed at a constant emperature of 15°C throughout 
the year, we conclude that the differential response 
of the cells to added GLPs (cf. table 1) is due to the 
altered circannual state of the experimental 
animals. The largest response is elicited during the 
summer, while cells isolated from winter fish fail 
to respond (Mommsen and Plisetskaya, unpublish- 
ed). This type of cell behaviour is by no means 
restricted to GLPs but also applies to glucagon 
[17]. 
Although the control rates for gluconeogenic 
flux and for lactate oxidation show considerable 
differences between individual fish (cf. tables 1,2), 
no significant differences are noticed over the 
course of a year (ANOVA, oxidation: D .F .= 
(4,26), F=2.04,  P>0.11;  glucose formation: 
D.F. = (4,26), F=0.94,  P>0.45),  resulting in the 
mean control rates given in the tables. However, 
our random block experimental design allows us to 
focus our analysis specifically on the effectiveness 
of GLP addition. 
With respect o the possible mechanism of ac- 
tion of GLPs, additional experiments with fish 
hepatocytes reveal that cAMP may not be involved 
as an intracellular messenger. When we tested the 
effects of GLPs on intracellular cAMP and cGMP 
in a series of block design experiments (table 3) no 
alterations were apparent in the amount of in- 
tracellular messengers, while glucagon caused the 
expected increase in cellular cAMP. 
4. DISCUSSION 
Our identification of a pronounced metabolic 
function of GLPs adds a new member to the list of 
hormones regulating gluconeogenesis in verte- 
brates. In addition, the physiological effect in 
piscine in vitro system is stronger than the response 
elicited by glucagon. If  this phenomenon also 
holds true for the in vivo situation, it will have im- 
portant implications on the general understanding 
of the regulation of glucose metabolism in verte- 
brate animals. Interestingly, teleost fish possess 
one GLP, which is homologous to mammalian 
GLP-I(7-37), the only mammalian GLP with 
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reported biological activity [1,2,18]. 
Large differences also exist in the amounts of 
GLPs available in vertebrate tissues. In mammals,  
GLP  concentrations in pancreas or gut fluctuate 
around 100 pmol /g  [20], which dwarfs in com- 
parison with values exceeding 120 nmol /g  in 
salmon pancreas [2]. The lowest concentrat ion of
GLP  (3.5 nM) applied in our experiments falls into 
the plasma concentrat ion range for salmonids 
(Plisetskaya, unpublished). 
Table 1 
Effects of peptide hormones on gluconeogenesis and COz release 
from lactate in isolated trout hepatocytes 
Oxidation Gluconeogenesis 
(/zmol CO2/g per h) (/zmol glycose/g per h) 
Control 9.99 _+ 0.70 (31) 2.28 +_ 0.29 (31) 
Salmon GLP 
(3.5 nM, March) + 6.4% _+ 4.3 (7) +20.0% + 5.9 (7) a 
(April) +10.8% + 5.8 (4) +21.8% + 6.1 (4) a 
(June) +27.5% + 15.3 (4) b +65.3% + 22.9 (4) a 
(Aug.) + 4.0% + 5.0 (2) + 12.5% + 0.5 (2) 
(15.5 nM, March) + 5.9% +_ 5.1 (6) +25.1% + 8.9 (6) a 
(April) + 14.0% _+ 4.3 (4) a + 16.3% + 3.9 (4) a 
(Sept.) + 4.6% + 1.9 (14) +34.2% +_ 5.1 (14) ~ 
Anglerfish GLP 
(3.5 nM, March) + 1.2% + 3.6 (6) +23.4% + 8.6 (6) a 
(15.5 nM, March) + 0.8% + 4.0 (5) +31.9% +_ 11.1 (5) a 
Catfish GLP 
(3.5 nM, June) + 37.0% + 11.7 (4) a + 87.7% +_ 21.8 (4) a 
Human GLP-I 
(3.5 nM, June) +18.8% + 8.8 (4) a +33.5% _+ 15.6(4) a
Human GLP-2 
(3.5 nM, June) + 9.8% + 13.1 (4) +19.3% + 21.9 (4) 
Bovine glucagon 
(10/zM, Sept.) + 3.2% + 3.7 (10) +31.5% +_ 7.0 (10) a 
Salmon glucagon 
(15 nM, Sept.) + 3.2% + 1.8 (6) + 7.3% _+ 2.2 (6) a 
a Significantly different from untreated control at p<0.01 
b Significantly different from untreated control at p<0.05 
Hormones were added after a 20 rain preincubation. Control rates are 
given as/zmol product formed in 60 rain per g packed cells _+ SE. See 
text for seasonal variation in control rate. In salmonid hepatocytes 
COz production reflects true substrate oxidation [26]. Therefore, 
division of oxidation values by 3 (carbon atoms in lactate) and 
multiplication of values for gluconeogenesis by 2 (theoretical 
incorporation of lactate into glucose) will yield the total substrate 
utilization. Rates after hormone xposure are given as percent change 
from the control rate +_ SE. In parentheses: number of independent 
determinations 
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Table 2 
Effects of glucagon-like peptides on gluconeogenesis and CO2 release 
from lactate in isolated coho salmon hepatocytes 
Oxidation Gluconeogenesis 
(umol CO2/g per h) (~mol glycose/g per h) 
Control 8.37 _+ 1.46 (6) 2.54 -+ 0.40 (6) 
Coho salmon GLP 
(3.5 nM) + 11.3% -+ 12.5 (3) + 18.4% _+ 7.7 (3) b 
(15.5 nM) - 3.3% -+ 1.2 (3) + 16.7% -+ 8.2 (3) 0 
(70.0 nM) + 2.7% -+ 3.2 (3) +39.3% _+ 12.7 (3) 0 
Anglerfish GLP 
(3.5 nM) - 1.9°70 (1) +22.9% (1) 
(15.5 nM) + 1.0% + 4.4 (2) +33.9% _+ 3.0 (2) 
All experiments were performed during March. See table 1 for 
explanation of experimental procedure and symbols 
July 1987 
Full activation of gluconeogenesis is achieved at 
3.5 nM GLP and is not accompanied by increases 
in cAMP (table 3). At higher concentrations (> 30 
nM GLP) minor increases in cAMP are detectable 
(Ottolenghi, C., personal communicat ion).  Our 
conclusion that GLPs exert their metabolic action 
without activating the hepatic adenylate cyclase 
system is in line with the observation that GLPs 
fail to compete for glucagon-binding sites on the 
hepatocyte surface [7,8]. The addit ional f inding 
Table 3 
Intracellular messengers in trout hepatocytes after hormonal 
treatment 
Treatment cAMP cGMP Flux 
(pmol/g) (pmol/g) (o7o increase) 
Control 386-+ 42 
(1o) 
Salmon GLP (15 nM) 396-+ 44 
(lO) 
Bovine glucagon (10 
/zM) 1120+ 316 (6) a 
Salmon glucagon (15 
nM) 
10.3_+0.7 (4) n/a 
11.2 _+ 0.4 31.6_+6.5 
(4) (10) a 
- 31.5_+7.0 
(10) a 
l l.7 _+ 1.6 7.3 _+ 2.2 
(4) (6) b 
a Significantly different from untreated cells at p<0.01 
b Significantly different from control and treatment with salmon GLP 
(/)<0.05, Student-Newman-Keuls-test) 
Values are given in pmol nucleotide per g packed hepatocytes _+ SE 
after a 15 min incubation with or without the respective hormone. 
( ) not determined. Flux: refers to the increase in flux through 
gluconeogenesis measured over a 2 h period as outlined in table 1. 
Experiments were carried out in September in a block design 
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that the brain, but not the hepatocyte membrane, 
contains specific GLP receptors [8,9] can only be 
reconciled with our results on hepatic action of 
GLPs if we postulate intracellular recognition sites 
for the GLPs. As a consequence, GLPs cannot in- 
terfere directly with the glucagon-dependent pro- 
duction of cAMP. 
GLPs also differ from glucagon in their effect 
on glycogenolysis. In coho salmon in vivo and in 
liver slices, salmonid GLPs appear to exert much 
less of a glycogenolytic action than either salmon 
or mammalian glucagon ([19] and Plisetskaya nd 
Ottolenghi, unpublished). This observation sup- 
plies preliminary evidence that the preferred target 
for GLPs is indeed the gluconeogenic pathway. 
The physiologically interesting outcome of our 
study is that such closely related peptide hormones 
(glucagon and GLP), forming part of the same 
precursor peptide (preproglucagon), encoded by 
the same gene [3,4,18], and similar in amino acid 
sequence [2] activate gluconeogenesis, albeit by 
differing modes of action. While glucagon binds to 
receptors on the hepatocyte surface, no outer 
membrane receptors have been found for GLPs 
[9]. Alternatively, intracellular receptors for pep- 
tide hormones, including glucagon [21], have been 
described, although it has been suggested that 
these may represent receptor molecules in the pro- 
cess of recycling (cf. [21]). 
Flux through hepatic gluconeogenesis is known 
to be stimulated hormonally by two distinct 
mechanisms. Glucagon and fl-adrenergic agonists 
lead to transient increases in intracellular cAMP, 
followed by protein phosphorylation [16], a mode 
of action which appears to be identical in mam- 
mals and in teleosts [12,14]. ae-Adrenergic agonists 
and vasopressin act through altering the intra- 
cellular Ca z+ distribution mediated by phospho- 
inositols, at times also resulting in protein 
phosphorylation [22]. While the exact regulatory 
sites causing altered flux through gluconeogenesis 
still await identification, the above distinction has 
been challenged by the recent description for 
hepatocytes of two-signal transduction systems for 
glucagon (adenylate cyclase and phosphodiester- 
ase, [23,241). Also, a cAMP-independent activa- 
tion of fructose-l,6-bisphosphatase has been 
noticed [25], possibly involving two membrane 
receptor populations. Our report on the potent 
physiological action of GLPs in conjunction with 
the alleged lack of GLP membrane receptors will 
make the sorting out of the control of gluco- 
neogenesis and the interaction of hormones, recep- 
tors and their intracellular messengers an even 
more challenging task. 
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